Oncology in the Precision Medicine Era. Value-Based Medicine / edited by Ravi Salgia.
Contributor(s): SpringerLink (Online service)
| Salgia, Ravi., editor
Material type:
E-bookSeries: (Medicine (Springer-11650)).Publisher: Cham : Springer International Publishing : Imprint: Springer, 2020Edition: 1st ed. 2020.Description: 1 recurso en línea (XIII, 351 páginas) : 28 ilustraciones, 16 ilustraciones a color.ISBN: 9783030314712.Subject: Cáncer -- Tratamiento
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RC270.8 RC254-282 O536 2020 (Browse shelf(Opens below)) | Acceso electrónico | eBook.10032061 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| No cover image available | ||||||||
| RC270.3.T84 ES International Journal of Biological Markers | RC270.3.T84 N58 2016 EB Novel Biomarkers in the Continuum of Breast Cancer | RC270.3.T84 R637 2016 EB Biomarkers in Neoplastic Neuropathology | RC270.8 RC254-282 O536 2020 Oncology in the Precision Medicine Era. Value-Based Medicine | RC270.8 2000 EB Principles and practice of the biologic therapy of cancer | RC270.8 2014 EB ALERT -- Adverse Late Effects of Cancer Treatment : Volume 2: Normal Tissue Specific Sites and Systems | RC270.8 2016 EB Current Strategies in Cancer Gene Therapy |
Healthcare Perspective -- Lung Cancer -- Esophageal and Gastric Cancer- Sarcomas -- Multiple Myeloma -- Pancreatic Cancer -- Colon Cancer -- Renal Cell Carcinoma -- Prostate Cancer -- Bladder Cancer -- Ovarian Cancer -- Genomic Cancer Risk Assessment -- Triple Negative Breast Cancer -- Melanoma -- Digital Patient Engagement and Social Media -- Hepatocellular Carcinoma -- Head and Neck Cancer -- Primary Central Nervous System Tumors -- Lymphoma.
This volume comprehensively reviews oncology in the precision medicine era of personalized care, latest developments in the field, and indications and clinical trials for the treatment of cancer with targeted therapies, immunotherapy, and epigenetic modulators. It thoroughly addresses concerns of various types of cancers including cancers of the head and neck, lung, colon, esophagus, bladder, pancreas, and breast; melanoma; multiple myeloma; hepatocellular carcinoma; renal cell carcinoma; and sarcomas. It is organized and written in a format that is easy to follow for both clinicians and non-clinical scientists interested in personalized medicine. Chapters cover the identification of the clinical problem and summary of recent findings, tumor biology and heterogeneity, genomics, examples of simple and complex cases, biological pathways, future clinical trials, and financial considerations. Oncology in the Precision Medicine Era: Value-Based Medicine will serve as a useful resource for medical oncologists and healthcare providers tailoring medicine to the needs of the individual patient, from prevention and diagnosis to treatment and follow up.
There are no comments on this title.